PARACAP PARACETAMOL 250MG5ML ORAL SUSPENSION

Country: Malasja

Lingwa: Ingliż

Sors: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Ixtrih issa

Ingredjent attiv:

Paracetamol

Disponibbli minn:

Health Pharm Marketing Sdn Bhd

INN (Isem Internazzjonali):

Paracetamol

Unitajiet fil-pakkett:

60 ml

Manifatturat minn:

UMEDA Co. Ltd

Fuljett ta 'informazzjoni

                                PARACAP
®
PARACETAMOL ORAL SUSPENSION
Consumer Medication Information Leaflet (RiMUP)
Paracetamol 250 mg/5 mL
1
WHAT IS IN THIS LEAFLET
1.
WHAT PARACAP
PARACETAMOL 250 MG/5 ML
ORAL SUSPENSION IS USED FOR
2.
HOW PARACAP PARACETAMOL
250 MG/5 ML ORAL
SUSPENSION WORKS
3.
BEFORE YOU USE PARACAP
PARACETAMOL 250 MG/5 ML
ORAL SUSPENSION
4.
HOW TO USE PARACAP
PARACETAMOL 250 MG/5 ML
ORAL SUSPENSION
5.
WHILE YOU ARE USING PARACAP
PARACETAMOL 250 MG/5 ML
ORAL SUSPENSION
6.
SIDE EFFECTS
7.
STORAGE AND DISPOSAL OF PARACAP
PARACETAMOL 250 MG/5 ML
ORAL SUSPENSION
8.
PRODUCT DESCRIPTION
9.
MANUFACTURER AND PRODUCT
REGISTRATION HOLDER
10.
DATE OF REVISION
WHAT PARACAP PARACETAMOL
250 MG/5 ML ORAL SUSPENSION
IS USED FOR
PARACAP PARACETAMOL 250
MG/5 ML ORAL SUSPENSION is
used for the relief of fever and pain
HOW PARACAP PARACETAMOL
250 MG/5 ML ORAL SUSPENSION
WORKS
Paracetamol
is
a
centrally
acting
analgesic and antipyretic with minimal
anti-inflammatory properties.
BEFORE YOU USE PARACAP
SUSPENSION PARACETAMOL 250
MG/5 ML
-
WHEN YOU MUST NOT USE IT:
Do not take this medicine if you have:
•
allergic to paracetamol or any
component
•
severe hepatic impairment or severe
active
liver disease
-BEFORE YOU START TO USE IT :
•
Paracetamol should be given
with
care
to
patients
with
impaired
kidney or liver function.
•
Large doses should be avoided in
patients
with
hepatic
impairment.
Paracetamol overdose may harm the
liver.
-TAKING OTHER MEDICINES:
HOW TO USE PARACAP
PARACETAMOL 250 MG/5 ML
ORAL SUSPENSION
Follow all directions given to you by
your pharmacist or doctor carefully.
They may differ from the information
contained in this leaflet.
If you do not understand the
instructions on the pack, ask your
pharmacist or doctor for help.
- HOW MUCH TO USE
For children aged 6 to 12 years. Give in
6 hourly intervals; not more than 4
times a day.
Age
Paracetamol Suspension
250 mg/5 mL
6-9
years
6.0 - 10.0 ml
9-12
years
10.0 - 15.0 mL
The above table is based on the average
weight-
age
grid
of
children.
If
you
know the body weight of yo
                                
                                Aqra d-dokument sħiħ
                                
                            

Karatteristiċi tal-prodott

                                148 mm
165 mm
165 mm
148 mm
NAME AND STRENGTH OF ACTIVE SUBSTANCE(S)
Paracetamol 250 mg/5 mL
Content of preservatives:
Methylparaben 9.00 mg and Propylparaben 1.50 mg/5 mL
Front
Child’s Weight
Paracetamol Suspension 250 mg/5 mL
In Kg
In Ib
20
30
40
44
6 m
L
9 m
L
13 m
L
66
88
PRODUCT DESCRIPTION
PARACAP PARACETAMOL 250ML/5ML ORAL SUSPENSION
is an orange-colored with orange flavoured in the form of a
suspension.
PHARMACODYNAMICS
Paracetamol is a centrally acting analgesic and antipyretic with
minimal anti-inflammatory properties.
Analgesic
The
mechanism
of
analgesic
action
has
not
been
fully
determined. Paracetamol may act predominantly by inhibiting
prostaglandin
synthesis
in
the
central
nervous
system
(specifically cyclooxygenase (COX)-2) and, to a lesser extent,
through a peripheral action by blocking pain-impulse generation.
The peripheral action may also be due to inhibition of
prostaglandin synthesis or to inhibition of the synthesis or
actions of other substances that sensitize pain receptors to
mechanical or chemical stimulation
Antipyretic
Paracetamol act centrally on the hypothalamic heat-regulating
center
to
produce
peripheral
vasodilatation
resulting
in
increased blood flow through the skin, sweating and heat loss.
Paracetamol reduces fever by inhibiting the formulation and
release
of
prostaglandins
in
the
CNS
and
by
inhibiting
endogenous pyrogens at the hypothalamic thermoregulator
center.
PHARMACOKINETICS
Following oral administration paracetamol is rapidly absorbed.
Paracetamol absorption takes place mainly in the small intestine
and therefore the rate of absorption is depending on the rate of
gastric emptying. It has been shown that drugs which delay
gastric emptying also delay the absorption of paracetamol
whereas metoclopramide (a drug which increases the rate of
gastric emptying) accelerates absorption of the analgesic
through the total amount absorbed doses not increase.
The presence of food in the stomach has also been reported to
reduce the rate of absorption of paracetamol. Alterations in

                                
                                Aqra d-dokument sħiħ
                                
                            

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Malajan 02-03-2020

Fittex twissijiet relatati ma 'dan il-prodott